Showing results (2081-2090 of 2,467) with videos related to

Sort By:
Pageof 247
Bipolar Disorders|February 26, 2025
Exploration of Genetic Liability to Insomnia and Substance Use Disorders in Patients With Bipolar DisorderLindsay M Melhuish Beaupre, Brandon J Coombes, Anthony Batzler, et al.
Nature|March 27, 2025
A broad-spectrum lasso peptide antibiotic targeting the bacterial ribosomeManoj Jangra, Dmitrii Y Travin, Elena V Aleksandrova, et al.
Biochemical and Biophysical Research Communications|March 9, 2005
A co-cultured skin model based on cell support membranesNiann-Tzyy Dai, Ming-Kung Yeh, Demeral David Liu, et al.
Nature Microbiology|October 3, 2025
Discovery and artificial intelligence-guided mechanistic elucidation of a narrow-spectrum antibioticDenise B Catacutan, Vian Tran, Autumn Arnold, et al.
Cancer Science|April 7, 2018
eIF2β, a subunit of translation-initiation factor EIF2, is a potential therapeutic target for non-small cell lung cancerIchidai Tanaka, Mitsuo Sato, Toshio Kato, et al.
Translational Andrology and Urology|November 30, 2017
Factors associated with acutely elevated serum creatinine following radical tumour nephrectomy: the Correlates of Kidney Dysfunction-Tumour Nephrectomy Database studyRobert J Ellis, Sharon J Del Vecchio, Keng Lim Ng, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 3, 2026
Associations among sleep quality, cognitive decline, and Alzheimer's disease pathology in older adults: A longitudinal studyLayaly Shihadeh, Mónica Rosselli, Joshua Conniff, et al.
Cancer Science|February 7, 2017
Identification of proteasomal catalytic subunit PSMA6 as a therapeutic target for lung cancerTomohiko Kakumu, Mitsuo Sato, Daiki Goto, et al.
Current Biology : CB|January 14, 2020
Non-enzymatic Activity of the α-Tubulin Acetyltransferase αTAT Limits Synaptic Bouton Growth in NeuronsCourtney E Coombes, Harriet A J Saunders, Anirudh G Mannava, et al.
Blood|December 4, 2008
Relevance of the immunoglobulin VH somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related chemoimmunotherapy regimensKatherine I Lin, Constantine S Tam, Michael J Keating, et al.
Pageof 247